Common Conundrums in Insulin Management
Live Webinar | Scheduled June 19, 2019 | 3:00 to 4:00 PM
CME CREDITS: 1.0
FACULTY: JUSTIN MOORE, MD, FACP
Endocrinologist, Guadalupe Clinic in Wichita, Kansas Adjunct Associate Professor at the University of Kansas School of Medicine
Justin is an endocrinologist who--in addition to maintaining a clinical practice at Guadalupe Clinic in Wichita, Kansas, working primarily with indigent patients--does consulting work at the clinical-public health intersection with Double Arrow Metabolism. It's in this role that he serves as a consultant with Health ICT, Medical Director of the Wichita Business Coalition on Health Care, and chairs the Chronic Disease Alliance of Kansas. He's also an endocrinology consultant with RubiconMD and Adjunct Associate Professor at the University of Kansas School of Medicine. He believes chronic diseases should fall at the top of the patient's problem list at any given visit, not at the bottom. He believes that health is hard to define and harder to measure, but that it's easier to achieve than people think. He believes true health saves money.
Diabetes mellitus affects more that 30 million of US adults and the Centers for Disease Control and Prevention last estimated that 30% of those affected are on an insulin regimen. In this webinar, Dr. Justin Moore, MD, FACP, will explain why the addition of a third oral or non-insulin medication is a relatively weak intervention for glycemic control; help primary care clinicians understand the differences between human insulins and analog insulins in patients with type 2 diabetes; outline strategies for dosing insulin; and explain why fingerstick blood glucose measurements have very limited value in patients not on insulin.
This lecture will be conducted as a one-hour live webinar. Registration is free. Participants will submit a survey at the end of the session to claim CME credit.
J. Nwando Olayiwola, MD, MPH, FAAFP
Anna Potapov, MD, MPH, MBA
Marc E. Walker, MD, MBA
Pooja Mittal, DO
By the end of the event, participants should:
Understand that addition of a third oral or non-insulin medication is a relatively weak intervention for glycemic control
Understand that human insulins--NPH and R--are 1/10 the expense of, and almost as good as, analog insulins in patients with type 2 diabetes
Outline strategies for dosing insulin by: basal titration; weight (kg); correction factor; carbohydrate ratio
Know that fingerstick blood glucose measurements have very limited value in patients not on insulin
AAFP CREDIT STATEMENT
This Live series activity, Optimizing Management of Common Specialty Conditions in the Primary Care Setting, from 07/01/2018 - 07/01/2019, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each webinar in the series is approved for 1.0 AAFP Prescribed credits unless otherwise noted.
AMA/AAFP Equivalency: AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
This Live series activity is eligible for Continuing Education credit from the American Association of Physician Assistants (AAPA) and the American Association of Nurse Practitioners (AANP). Physician Assistants (PAs) and Nurse Practitioners (NPs) may claim AMA PRA Category 1 equivalent credits per webinar based on their participation.